Yair Lotan, MD

Articles by Yair Lotan, MD

Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer

ByJoseph C. Hodges, MD, MBA,Yair Lotan, MD,Thomas P. Boike, MD,Rhonda Benton, BS, CMC,Alyson Barrier, BBA,Robert D. Timmerman, MD

May 9th 2012

Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.

Latest Updated Articles

Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer
Published: May 9th 2012 | Updated:

Yair Lotan, MD

Articles by Yair Lotan, MD

Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer

Latest Updated Articles

Trending on AJMC

FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis

Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD

Value-Based Care Interventions and Management of CKD Progression

HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs

NICU Nurses More Likely to Miss Tasks Due to Increased Workload